GEXVal Inc. is an R&D-focused drug discovery company founded in 2018 with a mission to develop pioneering solutions for rare and incurable diseases. The company's dedication to providing innovative and cost-effective treatment options in the Health Care industry sets it apart. GEXVal's recent ¥450.00M Series C investment on 04 December 2023 saw participation from notable investors including Mitsubishi UFJ Capital, SMBC Venture Capital, Axil Capital, UTC 2019 BioVentureFund, and Oita Venture Capital. This latest investment underscores confidence in GEXVal's commitment to improving lives through groundbreaking treatments, further solidifying its position as an innovative leader in the field.
GEXVal Inc.
Pioneering solutions to improve lives through innovative treatments for rare and incurable diseases.
Founded 2018
5 employees
Series C
Total: $1.56B
Health Care
General Information
Get notified when GEXVal Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track GEXVal Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Health Care
About GEXVal Inc.
Taxonomy: R&D-focused, drug discovery, treatments, rare diseases, incurable diseases, quality of life, cost-effective treatments
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series C | •••••• | 5 |
|
04 Dec 2023 |
| Series B | •••••• | 5 |
|
10 Sep 2021 |
| Series A | •••••• | - | 17 Jul 2018 |
GEXVal Inc. Alternatives & Competitors
GEXVal Inc. vs
DiaMedica Therapeutics Inc.
United States
$DMAC
Post Ipo Equity
38 employees
Biopharma, Biotechnology
GEXVal Inc. vs
Innovative gene transfer technology aiming to combat genetic disorders, infectious diseases, and can...
Series Unknown
Biotechnology, Health Care
GEXVal Inc. vs
Committed to developing and delivering top-quality dermatological treatments that enhance patient ca...
1 employees
Biotechnology, Health Care
FAQ About GEXVal Inc.
Pioneering solutions to improve lives through innovative treatments for rare and incurable diseases.
GEXVal Inc. was founded in 2018.
GEXVal Inc. operates in the following industries: Health Care.
GEXVal Inc. has approximately 5 employees.
GEXVal Inc. has completed 3 funding rounds, raising a total of $1.56B. The latest funding stage is Series C.
Top alternatives and competitors to GEXVal Inc. include DiaMedica Therapeutics Inc., Genecure, York Pharma, Alebund Pharmaceuticals, SparingVision. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GEXVal Inc. and DiaMedica Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors GEXVal Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.